Filter
551
Filtered Results: 551
Text search:
Preexposure
prophylaxis
Featured
Recommendations
51
New Publications
127
Language
Document type
No document type
295
Guidelines
124
Studies & Reports
87
Strategic & Response Plan
14
Manuals
11
Fact sheets
10
Infographics
5
Training Material
2
Situation Updates
2
Brochures
1
Countries / Regions
South Africa
20
Global
17
Kenya
16
Zambia
13
Asia
11
Uganda
11
Namibia
9
Malawi
8
Africa
8
Nigeria
7
Latin America and the Carribbean
6
Nepal
5
Ukraine
5
Philippines
5
Eastern Europe
5
Russia
5
India
5
Lesotho
4
Ghana
4
Sierra Leone
4
Zimbabwe
3
East and Southern Africa
3
Georgia
3
Botswana
3
Liberia
3
Myanmar / Burma
3
North Macedonia
2
Armenia
2
Tanzania
2
South–East Asia Region
2
Brazil
2
Ethiopia
2
Rwanda
1
Cameroon
1
Mozambique
1
Guinea-Bissau
1
Germany
1
Middle East and North Africa
1
Western and Central Europe
1
Paraguay
1
Belgium
1
Belarus
1
Bangladesh
1
Angola
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
127
Clinical Guidelines
43
Women & Child Health
25
Public Health
13
Key Resources
6
Pharmacy & Technologies
4
Toolboxes
HIV
341
COVID-19
19
TB
15
Caregiver
8
NTDs
7
Health Financing Toolbox
6
Rapid Response
5
Pharmacy
5
Mental Health
3
Planetary Health
3
Global Health Education
3
Ebola & Marburg
2
Polio
2
AMR
2
Specific Hazards
1
Refugee
1
NCDs
1
Conflict
1
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex C
The Lancet HIV. Volume 12, Issue 10e712-e721October 2025. This article from The Lancet HIV estimates the impact of the PEPFAR funding pause for PrEP on HIV infections in sub-Saharan Africa.
The new WHO recommendations for rabies immunization supersede the 2010 WHO position
on pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) for rabies. These updated
recommendations are based on new evidence and directed by public health needs that are cost-,
dose- and time-sparing...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex D
Mathematical modelling of lenacapavir: landscaping review on impact and cost–effectiveness
recommended
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex E
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex F
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex G Abstract
Adolescent girls and young women (AGYW) remain disproportionately affected by HIV in Eastern and Southern Africa (ESA), with 26 per cent of new infections attributed to this population. AGYW face many personal, social and structural barriers to access, uptake and use of traditional HIV prevention me...
In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may be offered as an additional HIV prevention option for people at substantial risk of HIV infection. CAB-LA is an injectable form of pre-exposure prophylaxis (PrEP) that has been shown to be highly effective at red...
3 June 2021. After 40 years of AIDS, charting a course to end the pandemic.
The report shows that countries with progressive laws and policies and strong and inclusive health systems have had the best outcomes against HIV. In those countries, people living with and affected by HIV are more likely t...
Rabies is a fatal viral disease, but is preventable in humans. The rabies virus is transmitted to humans through virus-laden saliva from a rabid animal, mostly dogs. The virus is shed in the saliva of an infected animal and can be introduced into another body through bites, scratches and any other ...
